{"id":15820,"date":"2018-10-04T08:47:35","date_gmt":"2018-10-04T08:47:35","guid":{"rendered":"https:\/\/celonpharma.com\/?p=15820"},"modified":"2018-10-04T08:47:35","modified_gmt":"2018-10-04T08:47:35","slug":"celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/","title":{"rendered":"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona"},"content":{"rendered":"

During the three days of the congress, more than 6,000 participants from all over the world: psychiatrists, psychologists and neurologists, will discuss the most important scientific reports in the field of diagnosis and treatment of brain diseases, from primary research to clinical development.<\/p>\n

Representatives of the Oncology Research Group will present three poster session topics on 08 October 2018.<\/p>\n

Poster 1:\u00a0Safety and pharmacokinetics study of inhaled esketamine after a single dose in healthy volunteers<\/em>
\nPresenter: Sylwia Janowska
\nPoster number: P.782<\/p>\n

Poster 2:\u00a0Pharmacodynamics of S-ketamine and ketamine racemate in rat PFC and HP after dry powder inhalation, intratracheal and intravenous<\/em>
\nPresenter: Anna Gajos-Draus
\nPoster number: P.783<\/p>\n

Poster 3:\u00a0CPL-500-036 \u2013 novel and highly bioavailable PDE10A inhibitor activates cyclic nucleotides depending signaling in rat striatum<\/em>
\nPresenter: Piotr Pankiewicz
\nPoster number: P.787<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

During the three days of the congress, more than 6,000 participants from all over the world: psychiatrists, psychologists and neurologists, will discuss the most important scientific reports in the field of diagnosis and treatment of brain diseases, from primary research to clinical development. Representatives of the Oncology Research Group will present three poster session topicsRead more »<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-15820","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nCelon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"During the three days of the congress, more than 6,000 participants from all over the world: psychiatrists, psychologists and neurologists, will discuss the most important scientific reports in the field of diagnosis and treatment of brain diseases, from primary research to clinical development. Representatives of the Oncology Research Group will present three poster session topicsRead more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-04T08:47:35+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/\",\"url\":\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/\",\"name\":\"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2018-10-04T08:47:35+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP","og_description":"During the three days of the congress, more than 6,000 participants from all over the world: psychiatrists, psychologists and neurologists, will discuss the most important scientific reports in the field of diagnosis and treatment of brain diseases, from primary research to clinical development. Representatives of the Oncology Research Group will present three poster session topicsRead more »","og_url":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/","og_site_name":"CelonGROUP","article_published_time":"2018-10-04T08:47:35+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/","url":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/","name":"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2018-10-04T08:47:35+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celon.group\/en\/2018\/10\/04\/celon-pharma-zaprezentuje-wyniki-badan-nad-esketamina-oraz-inhibitorem-pde10a-na-31-kongresie-european-college-of-neuropsychopharmacology-w-barcelonie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma will present results of its research on esketamine and the PDE10A inhibitor at the 31st European College of Neuropsychopharmacology Congress in Barcelona"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=15820"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15820\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=15820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=15820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=15820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}